RESEARCH OF THE SENTINEL LYMPH NODE AND MOLECULAR CLASSIFICATION OF THE ENDOMETRIAL CARCINOMA.

• Grant number: 24/14777-1
• Support Opportunities: Regular Research Grants
• Start date: August 01, 2025
• End date: July 31, 2028
• Field of knowledge: Health Sciences - Medicine - Pathological Anatomy and Clinical Pathology
• Principal Investigator: Glauco Baiocchi Neto
• Grantee: Glauco Baiocchi Neto
• Host Institution: A C Camargo Cancer Center. Fundação Antonio Prudente (FAP). São Paulo , SP, Brazil
• Associated researchers: Louise de Brot Andrade

Abstract

Sentinel lymph node (SLN) biopsy in endometrial cancer has emerged as a practical, reproducible, and reliable method for assessing lymph node status with the aim of better defining prognosis, guiding adjuvant treatment, and simultaneously minimizing treatment morbidity. However, there is currently no definition in the literature regarding the role of molecular profiling in conjunction with clinical-pathological data and SLN biopsy results in endometrial cancer. Additionally, there is no national data published on the prognostic role of molecular classification. Due to these factors and the relevance of the topic, we propose the design of this study. (AU)